Telmisartan Mitigates TNF-α-Induced Type II Collagen Reduction by Upregulating SOX‑9
The proinflammatory cytokine tumor necrosis factor-α (TNF-α)-induced degradation of extracellular matrix (ECM), such as type II collagen in chondrocytes, plays an important role in the development of osteoarthritis (OA). Telmisartan, an angiotensin II (Ang-II) receptor blocker, is a licensed drug us...
Saved in:
Published in | ACS omega Vol. 6; no. 17; pp. 11756 - 11761 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
American Chemical Society
04.05.2021
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!